Cerebrovascular Diseases Extra
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.1 | Q3 | 44.0% | 0.455 | Q3 | 57.6% |
| 2024 | 2.1 | Q3 | 47.5% | 0.503 | Q2 | 62.4% |
| 2023 | 2.0 | Q3 | 42.7% | 0.481 | Q3 | 63.6% |
| 2022 | 1.9 | 38.9% | 0.585 | Q2 | 71.2% | |
| 2021 | — | 30.4% | 0.715 | Q2 | 78.1% | |
| 2020 | — | — | 1.015 | Q1 | 85.6% | |
| 2019 | — | — | 1.016 | Q1 | 86.0% | |
| 2018 | — | — | 0.649 | Q2 | 72.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
1664-5456
country
CHcoverage
2015-2026